PEAK6’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
PEAK6's NVO Position: Q3 2026 in Review
PEAK6 opened a new position in Novo Nordisk (NVO) in Q3 2026: 58,026 shares worth $2.2M. The stake represents ﹤0.01% of the portfolio and ranks #1207 among its holdings. This is a return to the name: PEAK6 previously reported a position in NVO as recently as Q1 2026.
PEAK6 first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.8M in Q1 2025. 1,231 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- PEAK6 held 58,026 shares of Novo Nordisk worth $2.2M as of Q3 2026.
- Novo Nordisk was a new PEAK6 position in Q3 2026.
- Novo Nordisk made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #1207 holding.
- PEAK6 first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
- PEAK6's Novo Nordisk position peaked at $17.8M in Q1 2025.
- 1,231 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.